Corporate Profile

Aeterna Zentaris Inc. (TSX: AEZ, NASDAQ: AEZS) is a specialty biopharmaceutical company engaged in developing and commercializing novel treatments in oncology, endocrinology and women's health. The Company's pipeline encompasses compounds at various stages of development.

Contact us:

Aeterna Zentaris Inc.
1405 du Parc-Technologique Blvd.
Québec, Québec
G1P 4P5
Phone: (418) 652-8525
Fax: (418) 948-9191

Aeterna Zentaris and Sinopharm A-Think Sign Master Collaboration Agreement for Zoptarelin Doxorubicin in China more...>

Aeterna Zentaris Adds Hollings Cancer Center to Multi-National Phase 3 Trial in Endometrial Cancer more...>

FDA Issues Complete Response Letter for Aeterna Zentaris’ MacrilenTM NDA in Adult Growth Hormone Deficiency more...>
November 7, 2014
Issuance of FDA Complete Responce Lettre for Macrilen


Download PDF (125K)
Download and install Acrobat Reader